Valneva SE, a specialty vaccine company, announced it will report its consolidated financial results for the first nine months of 2026 on November 24, 2026. The company will host a live webcast at 3 p.m. CET/9 a.m. ET to discuss the results and provide a business update. Valneva focuses on developing vaccines for infectious diseases, including a Lyme disease vaccine candidate partnered with Pfizer and other advanced vaccine candidates. This update is important for investors tracking the company's progress and pipeline developments.
Valneva's upcoming financial report provides context for readers following vaccine and specialty biotech companies. For readers following the health sector, here is Pluang's market snapshot as of Nov 04, 2026 23:12 WIB: out of 150 priced US health stocks, 106 rose and 43 fell today. Notable movers include NUWE at USD 5.31 with a 10.15% decline and 100% sell order activity, Moderna (MRNA) at USD 250.38 with a 9.60% gain and 76% sell order activity, and Acadia Healthcare (ACHC) at USD 32.42 with a 9.45% gain and a typical hold time of 9 days.
Fox Factory Holding Corp. has appointed Troy Henige as its new Chief Technology Officer (CTO) to lead the company's technology vision, strategy, and product roadmap. This new role aims to enhance innovation, connect engineering strengths across the c...
3M Company has reached a historic $7.35 billion settlement to resolve personal injury claims related to exposure to PFAS, toxic chemicals known as "forever chemicals." The settlement covers about 99% of existing claims, potentially benefiting 115,000...
The global e-learning market is projected to grow from $275.9 billion in 2026 to $506.6 billion by 2032, with a CAGR of 10.62% driven by rising internet connectivity, corporate upskilling demands, and government digital education initiatives. North A...
Goldman Sachs Group, Inc. disclosed that it briefly held a combined stake exceeding 3% in Ontex Group NV shares as of October 27, 2026, with 566,115 voting rights and 1,965,157 financial instruments. However, by October 28, 2026, their combined posit...
BNP Paribas announced its monthly declaration of voting rights and shares as of October 31, 2026. The bank reported a total of 1,101,600,607 shares and an equal number of voting rights. This update is part of regulatory compliance under French commer...
